UA97663U - METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS - Google Patents
METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSISInfo
- Publication number
- UA97663U UA97663U UAU201411779U UAU201411779U UA97663U UA 97663 U UA97663 U UA 97663U UA U201411779 U UAU201411779 U UA U201411779U UA U201411779 U UAU201411779 U UA U201411779U UA 97663 U UA97663 U UA 97663U
- Authority
- UA
- Ukraine
- Prior art keywords
- patients
- multiple sclerosis
- pain syndrome
- treatment
- vertebrogenic
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 201000006417 multiple sclerosis Diseases 0.000 title abstract 2
- 208000008035 Back Pain Diseases 0.000 title 1
- 206010072005 Spinal pain Diseases 0.000 title 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 abstract 2
- 208000011580 syndromic disease Diseases 0.000 abstract 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- 229930003270 Vitamin B Natural products 0.000 abstract 1
- 230000007012 clinical effect Effects 0.000 abstract 1
- 229960002104 cyanocobalamin Drugs 0.000 abstract 1
- 235000000639 cyanocobalamin Nutrition 0.000 abstract 1
- 239000011666 cyanocobalamin Substances 0.000 abstract 1
- 229940084973 dexamethasone 4 mg Drugs 0.000 abstract 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 abstract 1
- 230000008034 disappearance Effects 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- DJGAAPFSPWAYTJ-UHFFFAOYSA-M metamizole sodium Chemical compound [Na+].O=C1C(N(CS([O-])(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 DJGAAPFSPWAYTJ-UHFFFAOYSA-M 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 235000019156 vitamin B Nutrition 0.000 abstract 1
- 239000011720 vitamin B Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Спосіб лікування вертеброгенного больового корінцевого синдрому у хворих на розсіяний склероз передбачає призначення симптоматичної терапії. Виконують паравертебральну блокаду лікарськими сумішами, до складу яких входять: ціанокобаламін (вітамін В) - 1000 мг, дексаметазон 4 мг, 2 % розчин лідокаїну - 2 мл, анальгін 50 % р-н - 2 мл, димедрол 1 % розчин 1 мл. 1 раз у 3 доби, курсом до 5 блокад до досягнення клінічного ефекту - зменшення або повного зникнення больового синдрому.A method of treating vertebrogenic painful root syndrome in patients with multiple sclerosis involves the appointment of symptomatic therapy. Perform paravertebral blockade drug mixtures, which include: cyanocobalamin (vitamin B) - 1000 mg, dexamethasone 4 mg, 2% lidocaine solution - 2 ml, analgin 50% rn - 2 ml, dimedrol 1% solution 1 ml. 1 time in 3 days, with a course of up to 5 blockades until clinical effect is achieved - reduction or complete disappearance of the pain syndrome.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201411779U UA97663U (en) | 2014-10-31 | 2014-10-31 | METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201411779U UA97663U (en) | 2014-10-31 | 2014-10-31 | METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA97663U true UA97663U (en) | 2015-03-25 |
Family
ID=53501236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201411779U UA97663U (en) | 2014-10-31 | 2014-10-31 | METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA97663U (en) |
-
2014
- 2014-10-31 UA UAU201411779U patent/UA97663U/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (en) | NEW METHODS. | |
| MX2021004821A (en) | Methods of cancer treatment with antagonists against pd-1 and pd-l1 in combination with radiation therapy. | |
| MX2020001768A (en) | Methods of treatment of osteoarthritis with transdermal cannabidiol gel. | |
| MX2022003072A (en) | Use of pridopidine for treating functional decline. | |
| AR086051A1 (en) | METHOD TO TREAT COLORRECTAL CANCER, COMPOSITION THAT INCLUDES AFLIBERCEPT, FOLINIC ACID, 5-FLUOROURACILO (5-FU) AND IRINOTECANO (FOLFIRI), ARTICLE MANUFACTURED, KIT | |
| MX2019003173A (en) | Combination therapy with controlled-release cnp agonists. | |
| MX2017017138A (en) | Targeted conjugates of ksp inhibitors. | |
| WO2016090024A3 (en) | Combination therapy for treatment of cancer | |
| PH12017500392A1 (en) | Medical treatments based on anamorelin | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| BR112016029437A2 (en) | methods for treatment and prevention of vascular instability diseases | |
| EA202193276A1 (en) | METHODS FOR THE TREATMENT OF CHOLANGIOCARCINOMA | |
| UA116499C2 (en) | (R) -PIRLINDOL AND ITS PHARMACEUTICALLY ACCEPTED SALTS FOR MEDICINAL USE | |
| BR112017002449A2 (en) | treatment of symptoms associated with androgen deprivation therapy | |
| UA97663U (en) | METHOD OF TREATMENT OF VERTEBROGENIC PAIN SYNDROME IN PATIENTS WITH MULTIPLE SCLEROSIS | |
| BR112018002433A2 (en) | pharmaceutical composition for migraine treatment | |
| ES2446215R2 (en) | THERAPEUTIC APPLICATION OF CD44 INHIBITING AGENTS AGAINST HUMAN LYMPHOBLASTIC LEUKEMIA (ALL). | |
| UA97011U (en) | METHOD OF TREATMENT OF WOMEN WITH PATHOLOGICAL PRELIMINARY PERIOD | |
| UA96506U (en) | METHOD OF TREATMENT OF NEUROPATHIES | |
| UA93361U (en) | METHOD OF TREATMENT OF OPIATES OF OPIATE ABSTRINENT SYNDROME | |
| UA83971U (en) | Method for treatment of hypertensis disease | |
| UA96488U (en) | A method for treating disorders of hemovascular hemostasis in patients with ischemic heart disease | |
| MX2016010919A (en) | 4-benzylsulfonyl-2-butenenitrile. |